EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Extended-Release Mixed Amphetamine Salts for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder: A Pilot, Randomized Double-Blind, Placebo-Controlled Trial

Frances R Levin iD, John J Mariani, Martina Pavlicova, C Jean Choi, Cale Basaraba, Amy L Mahony, Daniel J Brooks, Christina A Brezing, Nasir Naqvi

Journal of Attention Disorders · 2024-09 · 28 (11) · 1467-1481

DOI: 10.1177/10870547241264675 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Attention Disorders, online erschienen am 25.07.2024. Verfasst von Frances R Levin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division on Substance Use Disorders, New York State Psychiatric Institute, New York, NY, USA. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Delayed-Action Preparations, Marijuana Abuse, Central Nervous System Stimulants. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To determine if treatment of co-occurring adult ADHD and Cannabis Use Disorder (CUD) with extended-release mixed amphetamine salts (MAS-ER) would be effective at improving ADHD symptoms and promoting abstinence.

Method

A 12-week randomized, double-blind, two-arm pilot feasibility trial of adults with comorbid ADHD and CUD ( n = 28) comparing MAS-ER (80 mg) to placebo. Main outcomes: ADHD: ≥30% symptom reduction, measured by the Adult ADHD Investigator Symptom Rating Scale (AISRS). CUD: Abstinence during last 2 observed weeks of maintenance phase.

Results

Overall, medication was well-tolerated. There was no significant difference in ADHD symptom reduction (MAS-ER: 83.3%; placebo: 71.4%; p = .65) or cannabis abstinence (MAS-ER: 15.4%; placebo: 0%; p = .27). MAS-ER group showed a significant decrease in weekly cannabis use days over time compared to placebo ( p < .0001).

Conclusions

MAS-ER was generally well-tolerated. The small sample size precluded a determination of MAS-ER’s superiority reducing ADHD symptoms or promoting abstinence. Notably, MAS-ER significantly reduced weekly days of use over time.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Attention Deficit Disorder with HyperactivityDelayed-Action PreparationsMarijuana AbuseCentral Nervous System StimulantsHumansMaleAdultDouble-Blind MethodFemalePilot ProjectsTreatment OutcomeComorbidityMiddle AgedFeasibility StudiesAmphetaminesYoung AdultAmphetamine

Stichwörter der Autor:innen

adult ADHDadult ADHD treatmentcannabis use disordersubstance abuse

Substanzen

Delayed-Action PreparationsCentral Nervous System StimulantsAmphetaminesAmphetamine

Autor:innen und Institutionen

  • Division on Substance Use Disorders, New York State Psychiatric Institute, New York, NY, USA.
  • Department of Psychiatry, Vagelos College of Physicians and Surgeons of Columbia University, New York, NY, USA.
  • Department of Biostatistics, Columbia University, New York, NY, USA.
  • Division of Biostatistics, New York State Psychiatric Institute, New York, NY, USA.

ORCID-Profile: Frances R Levin

Förderung

  • NIDA NIH HHS
  • National Institute on Drug Abuse

Zitieren

APA

Levin, F. R., Mariani, J. J., Pavlicova, M., Choi, C. J., Basaraba, C., Mahony, A. L., Brooks, D. J., Brezing, C. A., & Naqvi, N. (2024). Extended-Release Mixed Amphetamine Salts for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder: A Pilot, Randomized Double-Blind, Placebo-Controlled Trial. Journal of Attention Disorders, 28(11), 1467-1481. https://doi.org/10.1177/10870547241264675

Vancouver

Levin FR, Mariani JJ, Pavlicova M, Choi CJ, Basaraba C, Mahony AL, et al. Extended-Release Mixed Amphetamine Salts for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder: A Pilot, Randomized Double-Blind, Placebo-Controlled Trial. Journal of Attention Disorders. 2024;28(11):1467-1481. doi:10.1177/10870547241264675

BibTeX
@article{Levin2024,
  author = {Levin, Frances R and Mariani, John J and Pavlicova, Martina and Choi, C Jean and Basaraba, Cale and Mahony, Amy L and Brooks, Daniel J and Brezing, Christina A and Naqvi, Nasir},
  title = {Extended-Release Mixed Amphetamine Salts for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder: A Pilot, Randomized Double-Blind, Placebo-Controlled Trial},
  journal = {Journal of Attention Disorders},
  year = {2024},
  volume = {28},
  number = {11},
  pages = {1467--1481},
  doi = {10.1177/10870547241264675}
}
Kostenlos starten →